FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 2091470
·
Received May 5, 2011
Report
- Report Number
- 2953161-2011-00109
- Event Type
- Injury
- Date Received
- May 5, 2011
- Date of Event
- December 22, 2009
- Report Date
- May 5, 2011
- Manufacturer
- W. L. GORE AND ASSOCIATES, INC.
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
METHOD: A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. RESULTS: THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. ADDITIONAL DEVICE IMPLANTED AND INVOLVED IN THIS EVENT: (B)(4).
Description of Event or Problem · 1
ON (B)(6), 2005, THIS PATIENT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6), 2009, FOLLOW-UP IMAGING IDENTIFIED AN INFECTED PARARENAL ABDOMINAL AORTIC ANEURYSM, INFECTED AORTIC STENT GRAFT, AND A TYPE I ENDOLEAK. ON (B)(6), 2009, THE GORE EXCLUDER AAA ENDOPROSTHESES WERE EXPLANTED DUE TO THE INFECTION. THE PATIENT TOLERATED THE PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W. L. GORE AND ASSOCIATES, INC. | WLG325 | 042190211 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Hospitalization| R | ZOCOR| CEFTRIAXONE| VANCOMYCIN| PATIENT MEDICATIONS INCLUDE: LOPRESSOR |